Sands Capital is an active, long-term investor in innovative businesses globally. Their approach combines fundamental analysis with creative thinking to identify growth businesses.

Sands Capital

Sands Capital | 12,800 followers on LinkedIn. Active, long-term investors in leading innovative businesses, globally. | Sands Capital is an active, long-term investor in leading innovative growth businesses, globally. Our approach combines analytical rigor and creative thinking to identify high-quality growth businesses that are creating the future. Through an integrated investment platform spanning venture capital, growth equity and public equity, we provide growth capital solutions to institutions and fund sponsors in more than 40 countries.

Venture Partner at Sands Capital Management

Gene Riechers

FinTech Entrepreneur

Jeff Lewis

Chris Linthwaite

Managing Partner at Sands Capital Ventures

Scott Frederick

Despite the short-term pressure on some software stocks, the long-term opportunity in select businesses remains strong. Learn why our analysts see potential in businesses offering mission-critical, multiproduct platforms with fast time-to-value. https://lnkd.in/e4fd8V_R #verticalsoftware #software

Sands Capital believes we have a responsibility to engage with our companies to understand and influence the potential impact of their operations. As part of our focus on the fight against #modernslavery , we continue to partner with Hope for Justice and Slave-Free Alliance to better understand and seek to mitigate modern slavery risks at both the portfolio and operational levels at our firm. Learn more from Hope for Justice about this global issue: https://lnkd.in/em45_jUF

We are proud to lead the Series D financing for Cytovale , an innovative medical diagnostics leader focused on advancing early detection technologies. This funding will accelerate commercial and operational expansion of Cytovale’s IntelliSep, building on its early clinical success. We’re thrilled to support Ajay Shah , Henry Tse , and the entire team as they continue to transform the diagnoses of fast-moving and immune-mediated diseases. Learn more about Cytovale’s role as an innovator in the health care industry here: https://lnkd.in/dMtPX9gT

Change can create uncertainty in financial markets, but it also has the potential to unlock opportunities for many of the businesses we own. Tune in to hear Sr. Portfolio Manager Dave Levanson, CFA, discuss the on-going journey of these businesses, why we continued to own them through tough times, and what we can expect from them going forward. https://lnkd.in/eKaK5DfJ

Investing for the long term takes courage and the support of a culture rooted in trust. Find out how Sands Capital Director of Research Michael Raab , CFA, keeps his research team focused on what matters most. https://lnkd.in/eKqxrmRV

Portfolio Manager and Sr. Research Analyst Daniel Pilling joined Caroline Hyde and Edward Ludlow on Bloomberg to discuss Sands Capital’s outlook on NVIDIA ’s long-term growth drivers and the company’s role in the broader evolution of artificial intelligence ahead of their Q2 earnings report. Hear more about our views on remaining competitive in the semiconductor industry amid a global acceleration in demand for compute power: https://lnkd.in/ePD_mmwP Disclosures: https://lnkd.in/e9k3T4-M

Generative artificial intelligence could strengthen the leadership positions of businesses that can invest in the infrastructure, data, and talent needed to run this transformative technology. Learn why we believe owning industry-leading companies is critical to value creation. https://lnkd.in/eEddXYtv

Sands Capital Management, LLC is pleased to be a signatory to the UK Stewardship Code. This designation reflects our commitment to responsible investment on behalf of clients globally. Learn more about the code and our stewardship work. https://lnkd.in/ersJXAmd

We are delighted to co-lead Anduril Industries ' Series F funding round, a significant milestone in its ongoing mission to disrupt the defense industry and provide modernized defense capabilities for the U.S. and its Allies. Our respect for Anduril's leadership team is longstanding, particularly its ability to consistently execute against their objectives. We are excited to champion Anduril's journey and foster our long-term partnership. Learn more about the significant steps Anduril is taking to modernize the defense industry: https://lnkd.in/efzxsFQy

We are thrilled to participate in the most recent financing round of Credo AI . We are excited to watch Navrina Singh , Eli Chen , and the team as they continue to reinforce their commitment to enabling organizations worldwide to adopt AI responsibly while driving innovation and operational efficiency. https://lnkd.in/eSG7KFty

msh id	COM:SANDSCAPITALVENTURES
symbol	-
name	Sands Capital
homepage url	https://sandscapitalventures.com
country	US
sector	Financial Services & Finance
industry	Investment Management
market	PRIVATE
employee count	-
crunchbase url	https://www.crunchbase.com/organization/sands-capital-ventures
linkedin url	https://www.linkedin.com/company/sands-capital-management
founders	-

market cap	-
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-
growth ebitda ratio	-
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-
growth gross profit ratio	-

SAND

COM:SANDSCAPITALVENTURES

Sands Capital

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	-
cost of revenue	-
depreciation and amortization	-
ebitda	-
ebitda ratio	-
eps	-
eps diluted	-
operating expenses	-
operating income	-
operating income ratio	-

accounts receivables	-
capital expenditure	-
cash at beginning of period	-
cash at end of period	-
inventory	-
working capital ttm	-

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-